Funding National Council for Scientific and Technological Development (CNPq, MCTI, Brazil) grant number 406484/2022-8 (INCT BioOncoPed), grant number 400120/2023-2, CNPq MAI/DAI and Centro de Diagnsticos Antomo-Patolgicos CEDAP
Use in Patients with Liver Disease: Ondansetron is primarily metabolized by the liver, so caution is advised when prescribing this medication to individuals with severe liver impairment
It contains 0.9 percent benzyl alcohol as a preservative
Gradual Start for Lasting Results During your initial weeks on semaglutide GLP-1, our team will start you on a low dose, gradually increasing it to help minimize side effects
Adems, la textura de abdomen mejora si haba celulitis o estras
Your provider will discuss whether compounded therapy is appropriate for your goals and health profile during your consult